Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kemball-Cook

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Human Mutation|January 4, 2001
Factor VII deficiency and the FVII mutation databaseJ H McVey, E Boswell, A D Mumford, et al.
British Journal of Haematology|July 11, 2000
Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish familyR Schwaab, J Oldenburg, G Kemball-Cook, et al.
Biochemistry|June 12, 1998
The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modelingA W Ashton, M K Boehm, D J Johnson, et al.
British Journal of Haematology|April 1, 1991
Variable inactivation of human factor VIII from different sources by human factor VIII inhibitorsJ D Littlewood, S A Bevan, G Kemball-Cook, et al.
Blood|January 15, 1998
The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIIIK Amano, R Sarkar, S Pemberton, et al.
Blood|February 7, 2001
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIaS W Pipe, E L Saenko, A N Eickhorst, et al.
British Journal of Haematology|November 11, 1999
Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954-->Leu substitution in the factor VIII A3 domainD M Keeling, K Sukhu, G Kemball-Cook, et al.
British Journal of Haematology|April 1, 1979
Anticoagulant activities of high and low molecular weight heparin fractionsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.
Thrombosis and Haemostasis|April 1, 1995
Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicityE Gray, J Tubbs, S Thomas, et al.
The Journal of Biological Chemistry|May 9, 1998
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant functionG Kemball-Cook, D J Johnson, O Takamiya, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Human Mutation|January 4, 2001
Factor VII deficiency and the FVII mutation databaseJ H McVey, E Boswell, A D Mumford, et al.
British Journal of Haematology|July 11, 2000
Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish familyR Schwaab, J Oldenburg, G Kemball-Cook, et al.
Biochemistry|June 12, 1998
The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modelingA W Ashton, M K Boehm, D J Johnson, et al.
British Journal of Haematology|April 1, 1991
Variable inactivation of human factor VIII from different sources by human factor VIII inhibitorsJ D Littlewood, S A Bevan, G Kemball-Cook, et al.
Blood|January 15, 1998
The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIIIK Amano, R Sarkar, S Pemberton, et al.
Blood|February 7, 2001
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIaS W Pipe, E L Saenko, A N Eickhorst, et al.
British Journal of Haematology|November 11, 1999
Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954-->Leu substitution in the factor VIII A3 domainD M Keeling, K Sukhu, G Kemball-Cook, et al.
British Journal of Haematology|April 1, 1979
Anticoagulant activities of high and low molecular weight heparin fractionsT W Barrowcliffe, E A Johnson, C A Eggleton, et al.
Thrombosis and Haemostasis|April 1, 1995
Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicityE Gray, J Tubbs, S Thomas, et al.
The Journal of Biological Chemistry|May 9, 1998
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant functionG Kemball-Cook, D J Johnson, O Takamiya, et al.
Pageof 6